Kura Oncology, Inc
Kura Oncology, Inc., based in San Diego, CA, is dedicated to discovering and developing innovative cancer therapeutics aimed at improving patient outcomes and addressing significant unmet needs in oncology. The company focuses on precision medicines and the development of novel therapies designed to selectively target cancer cells, thereby enhancing clinical benefits for patients with various types of cancers, including acute leukemias and head and neck cancer.
With a commitment to pioneering new approaches to cancer treatment, Kura collaborates with established standards of care to explore combination therapies that provide patients with a better chance for long-term remissions. Their pipeline includes promising investigational drugs such as Ziftomenib, Tipifarnib, and KO-2806, reflecting their mission to help patients lead longer, healthier lives through cutting-edge science and compassionate care.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.